Surgical Treatment of Metastatic Bone Disease—When Decisions at End-of-Life Really Makes the Difference

摘要

The current era within the field of surgical treatment of metastatic bone disease (MBD) is best described as the beginning of a paradigm shift. We are moving away from the thought of that all the patients are at their very terminal stage when they present with a bony lesion in need of surgical intervention, and thus treating them with a surgical solution inducing a minimal surgical trauma, to treatment modalities aiming to preserve or improve the quality of life, or even for some selected cases, hoping to prolong survival by performing metastasectomy with a tumor-free surgical margin [1,2].